Facebook (NASDAQ:FB) Plans to Reorganizing Oculus Rift- Applied DNA Sciences, (NASDAQ:APDN)

Shares of Facebook (NASDAQ:FB) [Trend Analysis] runs in leading trade, it surging 0.48% to traded at $120.78. The firm has price volatility of 1.90% for a week and 2.02% for a month. Its beta stands at 0.68 times. Facebook’s (FB) Oculus Rift is reorganizing, with CEO Brendan Iribe stepping down from the role to lead a new division of the virtual reality headset maker. Oculus is creating two groups, one focused on PCs and the other on mobile, Iribe wrote in a blog post. He’ll be leading the PC unit, and Jon Thomason, who joined Oculus in August as its head of software, will take over the mobile group.

Iribe said he, Thomason and Facebook Chief Technology Officer Mike Schroepfer will work together to find a new Oculus CEO.”With our growth and product strategy, we’ve decided to establish new PC and mobile VR groups to be more focused, strengthen development and accelerate our road map,” he said in the post. “Facebook is committed to working on VR for the long term.”

Iribe, who co-founded Oculus with Palmer Luckey, has pushed for the company to replicate Alphabet Inc.’s success with spreading the Android operating system. Under his leadership, Oculus struck partnerships with other hardware producers to distribute the company’s software. For example, the company’s headsets and Samsung’s Gear VR both work on the same platform.

While the Oculus Riftdevice requires connection to a fast PC with a powerful graphics card to work properly, Gear VR content only requires the computing power of a smartphone. Narrow down four to firm performance, its weekly performance was 1.92% and monthly performance was 4.46%. The stock price of FB is moving up from its 20 days moving average with 1.61% and isolated negatively from 50 days moving average with -2.38%.

Applied DNA Sciences,  (NASDAQ:APDN) [Trend Analysis] luring active investment momentum, shares an advance 2.38% to $2.15. Applied DNA Sciences,  (NASDAQ: APDN) reported that through one of its partners, the Company will provide its SigNature T DNA products and services platform to empower textile supply chain security for one of the largest US-based retailers over an extended multi-year period with established incomethresholds.

Stated Dr. James A. Hayward, President and CEO of Applied DNA Sciences, “The textile industry is under surged pressure to deliver high quality products at competitive prices. Price competition can lead to compromise in the supply chain. The retailer that selected SigNature T over and above any other system in the world did so because they learned first-hand what it means to truly know your supply chain.

Assuring quality in complex global supply chains is no small task and is too often under-estimated. It requires commitment not only in time and resources, but a genuine belief that if you start with the purest fiber, your trusted network will keep it in your product to perform as nature intended.” The total volume of 7973 shares held in the session was surprisingly higher than its average volume of 54.80 shares. EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at 18.10%, and looking further price to next year’s EPS is 110.50%. While take a short look on price to sales ratio, that was 7.70.

 

About Richard Avery

He is a capital projects manager and process design engineer at a large-cap company. He has renowned MBA degree. Before joining SWR, he was a freelance writer for renounce tech websites. He is currently studying for CFP exam. Interests: Tech stocks, Economic Markets, Blue-chips.

Leave a Reply

Your email address will not be published. Required fields are marked *